Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 12, 2013
Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screeningCatherine Moorwood, Tejvir S KhuranaHuman Molecular Genetics|June 1, 2014
Caspase-12 ablation preserves muscle function in the mdx mouseCatherine Moorwood, Elisabeth R BartonJournal of Visualized Experiments : Jove|February 15, 2013
Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophiesCatherine Moorwood, Min Liu, Zuozhen Tian, et al.Hormone Research in Paediatrics|January 31, 2024
Congenital Central Hypothyroidism Caused by Novel Variants in IGSF1 Gene: Case Series of 3 PatientsHelen MacGloin, Nadia Schoenmakers, Catherine Moorwood, et al.Journal of Biomolecular Screening|November 1, 2012
A cell-based high-throughput screening assay for posttranscriptional utrophin upregulationCatherine Moorwood, Neha Soni, Gopal Patel, et al.Skeletal Muscle|July 16, 2014
Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscleCatherine Moorwood, Anastassios Philippou, Janelle Spinazzola, et al.Plos One|January 5, 2012
Translational regulation of utrophin by miRNAsUtpal Basu, Olga Lozynska, Catherine Moorwood, et al.Plos One|October 27, 2011
Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screeningCatherine Moorwood, Olga Lozynska, Neha Suri, et al.Journal of Cell Science|July 1, 2010
Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neuronsW Thomas Clarke, Ben Edwards, Karl J A McCullagh, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 7, 2023
ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizuresElena Poggio, Lucia Barazzuol, Andrea Salmaso, et al.Pageof 2